| Anti-miR delivery strategies to bypass the blood-brain barrier in glioblastoma therapy DG Kim, KH Kim, YJ Seo, H Yang, EG Marcusson, E Son, K Lee, JK Sa, ... Oncotarget 7 (20), 29400, 2016 | 35 | 2016 |
| Anti-SEMA3A antibody: a novel therapeutic agent to suppress glioblastoma tumor growth J Lee, YJ Shin, K Lee, HJ Cho, JK Sa, SY Lee, SH Kim, J Lee, Y Yoon, ... Cancer Research and Treatment: Official Journal of Korean Cancer Association …, 2018 | 25 | 2018 |
| Synthesis and anticancer activity of benzoselenophene and heteroaromatic derivatives of 1, 2, 9, 9a-tetrahydrocyclopropa [c] benzo [e] indol-4-one (CBI) AB Mhetre, H Lee, H Yang, K Lee, DH Nam, D Lim Organic & biomolecular chemistry 15 (5), 1198-1208, 2017 | 21 | 2017 |
| Promising therapeutic efficacy of GC1118, an anti-EGFR antibody, against KRAS mutation-driven colorectal cancer patient-derived xenografts HW Lee, E Son, K Lee, Y Lee, Y Kim, JC Lee, Y Lim, M Hur, D Kim, ... International Journal of Molecular Sciences 20 (23), 5894, 2019 | 16 | 2019 |
| Therapeutic efficacy of GC1118, a novel anti-EGFR antibody, against glioblastoma with high EGFR amplification in patient-derived xenografts K Lee, H Koo, Y Kim, D Kim, E Son, H Yang, Y Lim, M Hur, HW Lee, ... Cancers 12 (11), 3210, 2020 | 12 | 2020 |
| Novel semi-replicative retroviral vector mediated double suicide gene transfer enhances antitumor effects in patient-derived glioblastoma models M Lee, YS Kim, K Lee, M Kang, H Shin, JW Oh, H Koo, D Kim, Y Kim, ... Cancers 11 (8), 1090, 2019 | 9 | 2019 |
| Facilitating tailored therapeutic strategies for glioblastoma through an orthotopic patient-derived xenograft platform HW Lee, K Lee, DG Kim, HK Yang, DH Nam Universidad de Murcia. Departamento de Biología Celular e Histología, 2016 | 7 | 2016 |
